Sort
82,697 grants matching “vaccine development”
Isolation and Deep Sequencing of Monoclonal Antibodies Against HIV
$2,287,556John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Northeast Biodefense Center
$2,286,398W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2009 · AI
Mayo Clinic Breast Cancer SPORE
$2,285,993Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2023 · CA
Center for Experimental Infectious Disease Research
$2,284,780Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2012 · GM
Systems Immunology profiling of respiratory viral infections in vulnerable populations
$2,283,860Carmen R Mikacenic · Benaroya Research Inst At Virginia Mason · U19 · FY2023 · AI
Systems Immunology profiling of respiratory viral infections in vulnerable populations
$2,283,860Carmen R Mikacenic · Benaroya Research Inst At Virginia Mason · U19 · FY2025 · AI
Systems Immunology profiling of respiratory viral infections in vulnerable populations
$2,283,860Carmen R Mikacenic · Benaroya Research Inst At Virginia Mason · U19 · FY2024 · AI
Systems Immunology profiling of respiratory viral infections in vulnerable populations
$2,283,860Carmen R Mikacenic · Benaroya Research Inst At Virginia Mason · U19 · FY2022 · AI
NIAID Microbiome Program
$2,283,664Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
CARIBBEAN PRIMATE RESEARCH CENTER
$2,283,320Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2017 · OD
CARIBBEAN PRIMATE RESEARCH CENTER
$2,283,320Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2019 · OD
CARIBBEAN PRIMATE RESEARCH CENTER
$2,283,320Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2016 · OD
Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
$2,282,544Jasmin Anita Tiro · Ut Southwestern Medical Center · UM1 · FY2021 · CA
Interplay of B cells and HIV Leading to Broad Neutralizing Antibody Responses
$2,282,525Pascal Poignard · International Aids Vaccine Initiative · U19 · FY2013 · AI
Center for Molecular, Cellular, and Translational Immunological Research
$2,282,366William R Green · Dartmouth College · P20 · FY2010 · RR
Center for Molecular, Cellular, and Translational Immunological Research
$2,282,366William R Green · Dartmouth College · P20 · FY2009 · RR
Center for Molecular, Cellular, and Translational Immunological Research
$2,282,366William R Green · Dartmouth College · P20 · FY2008 · RR
Center for Experimental Infectious Disease Research
$2,281,950Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2011 · RR
Vaccine Induced Immunity in the Young and Aged
$2,281,308Rafi Ahmed · Emory University · U19 · FY2020 · AI
THE IMPACTA PERU CLINICAL TRIALS UNIT
$2,280,954Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · U01 · FY2011 · AI
MIDAS Center for Communicable Disease Dynamics
$2,279,902Marc Lipsitch · Harvard School Of Public Health · U54 · FY2014 · GM
Development of a Vaccine for HIVAIDS: Humoral Immunity
$2,279,616Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses
$2,278,773Integral Molecular · N01 · FY2009 · AI
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
$2,278,757Daniel William Cramer · Brigham And Women'S Hospital · P50 · FY2007 · CA
Clinical Trials of Biodefense Vaccines (Dengue)
$2,278,429Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI